… The axillary and more proximal veins are involved and there is a risk of PE, necessitating
anticoagulation treatment using the same treatment regimens used for lower extremity DVT. …

… In the DVT patients, the primary efficacy outcome, the rate of recurrent venous thromboembolism
at 3 months, was similar in the idraparinux and conventionally-treated groups (2.9% …

… D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism:
… unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. …

… In our opinion and that of others,"14 operative management of venous thromboembolism
should be … We believe that anticoagulants represent the treatment of choice for venous thrombo…

… Cancer increases the risk of thromboembolic events, especially in people receiving
anticoagulation treatments. … People with cancer also have different benefits and risks from …

… We usually use the same type of anticoagulant that was used for the acute phase of treatment.
For patients without cancer who have a creatinine clearance of at least 30 mL/min, this is …

… the treatment of patients with venous thromboembolic disease … and reasons for treatment of
venous thromboembolism (VTE), … For those who receive prolonged anticoagulant treatment, …

… Anticoagulant therapy is the cornerstone of treatment of venous thromboembolism (VTE).
Such treatment is divided into two stages. Rapid initial …

… often prescribed extended anticoagulation therapy as … anticoagulant treatment of VTE has
been divided into 3 stages: initial therapy, long-term treatment, and extended anticoagulation…

… We conducted a meta-analysis to assess the DOAC in acute venous thromboembolism. …
the different anticoagulants. P < 0.05 for interaction indicates that the effect of treatment differs …